BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19053947)

  • 1. Trafficking of immature DeltaF508-CFTR to the plasma membrane and its detection by biotinylation.
    Luo Y; McDonald K; Hanrahan JW
    Biochem J; 2009 Apr; 419(1):211-9, 2 p following 219. PubMed ID: 19053947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low temperature induces the delivery of mature and immature CFTR to the plasma membrane.
    Rennolds J; Boyaka PN; Bellis SL; Cormet-Boyaka E
    Biochem Biophys Res Commun; 2008 Feb; 366(4):1025-9. PubMed ID: 18096515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cystic fibrosis transmembrane conductance regulator (CFTR) nucleotide-binding domain 1 (NBD-1) and CFTR truncated within NBD-1 target to the epithelial plasma membrane and increase anion permeability.
    Clancy JP; Hong JS; Bebök Z; King SA; Demolombe S; Bedwell DM; Sorscher EJ
    Biochemistry; 1998 Oct; 37(43):15222-30. PubMed ID: 9790686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimeric cystic fibrosis transmembrane conductance regulator exists in the plasma membrane.
    Ramjeesingh M; Kidd JF; Huan LJ; Wang Y; Bear CE
    Biochem J; 2003 Sep; 374(Pt 3):793-7. PubMed ID: 12820897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rescue of DeltaF508-CFTR (cystic fibrosis transmembrane conductance regulator) by curcumin: involvement of the keratin 18 network.
    Lipecka J; Norez C; Bensalem N; Baudouin-Legros M; Planelles G; Becq F; Edelman A; Davezac N
    J Pharmacol Exp Ther; 2006 May; 317(2):500-5. PubMed ID: 16424149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface expression of the cystic fibrosis transmembrane conductance regulator mutant DeltaF508 is markedly upregulated by combination treatment with sodium butyrate and low temperature.
    Heda GD; Marino CR
    Biochem Biophys Res Commun; 2000 May; 271(3):659-64. PubMed ID: 10814518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sildenafil (Viagra) corrects DeltaF508-CFTR location in nasal epithelial cells from patients with cystic fibrosis.
    Dormer RL; Harris CM; Clark Z; Pereira MM; Doull IJ; Norez C; Becq F; McPherson MA
    Thorax; 2005 Jan; 60(1):55-9. PubMed ID: 15618584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Curcumin does not stimulate cAMP-mediated chloride transport in cystic fibrosis airway epithelial cells.
    Dragomir A; Björstad J; Hjelte L; Roomans GM
    Biochem Biophys Res Commun; 2004 Sep; 322(2):447-51. PubMed ID: 15325250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rab4GTPase modulates CFTR function by impairing channel expression at plasma membrane.
    Saxena SK; Kaur S; George C
    Biochem Biophys Res Commun; 2006 Mar; 341(1):184-91. PubMed ID: 16413502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correction of the Delta phe508 cystic fibrosis transmembrane conductance regulator trafficking defect by the bioavailable compound glafenine.
    Robert R; Carlile GW; Liao J; Balghi H; Lesimple P; Liu N; Kus B; Rotin D; Wilke M; de Jonge HR; Scholte BJ; Thomas DY; Hanrahan JW
    Mol Pharmacol; 2010 Jun; 77(6):922-30. PubMed ID: 20200141
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynasore inhibits removal of wild-type and DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) from the plasma membrane.
    Young A; Gentzsch M; Abban CY; Jia Y; Meneses PI; Bridges RJ; Bradbury NA
    Biochem J; 2009 Jul; 421(3):377-85. PubMed ID: 19442237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Base treatment corrects defects due to misfolding of mutant cystic fibrosis transmembrane conductance regulator.
    Namkung W; Kim KH; Lee MG
    Gastroenterology; 2005 Dec; 129(6):1979-90. PubMed ID: 16344066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific rescue of cystic fibrosis transmembrane conductance regulator processing mutants using pharmacological chaperones.
    Wang Y; Bartlett MC; Loo TW; Clarke DM
    Mol Pharmacol; 2006 Jul; 70(1):297-302. PubMed ID: 16624886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S-nitrosylating agents: a novel class of compounds that increase cystic fibrosis transmembrane conductance regulator expression and maturation in epithelial cells.
    Zaman K; Carraro S; Doherty J; Henderson EM; Lendermon E; Liu L; Verghese G; Zigler M; Ross M; Park E; Palmer LA; Doctor A; Stamler JS; Gaston B
    Mol Pharmacol; 2006 Oct; 70(4):1435-42. PubMed ID: 16857740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TGFbeta down-regulation of the CFTR: a means to limit epithelial chloride secretion.
    Howe KL; Wang A; Hunter MM; Stanton BA; McKay DM
    Exp Cell Res; 2004 Aug; 298(2):473-84. PubMed ID: 15265695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rescue of ΔF508-CFTR trafficking via a GRASP-dependent unconventional secretion pathway.
    Gee HY; Noh SH; Tang BL; Kim KH; Lee MG
    Cell; 2011 Sep; 146(5):746-60. PubMed ID: 21884936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ERp29 regulates DeltaF508 and wild-type cystic fibrosis transmembrane conductance regulator (CFTR) trafficking to the plasma membrane in cystic fibrosis (CF) and non-CF epithelial cells.
    Suaud L; Miller K; Alvey L; Yan W; Robay A; Kebler C; Kreindler JL; Guttentag S; Hubbard MJ; Rubenstein RC
    J Biol Chem; 2011 Jun; 286(24):21239-53. PubMed ID: 21525008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue of DeltaF508 and other misprocessed CFTR mutants by a novel quinazoline compound.
    Loo TW; Bartlett MC; Clarke DM
    Mol Pharm; 2005; 2(5):407-13. PubMed ID: 16196493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted quantitation of overexpressed and endogenous cystic fibrosis transmembrane conductance regulator using multiple reaction monitoring tandem mass spectrometry and oxygen stable isotope dilution.
    Jiang H; Ramos AA; Yao X
    Anal Chem; 2010 Jan; 82(1):336-42. PubMed ID: 19947594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proinflammatory effect of sodium 4-phenylbutyrate in deltaF508-cystic fibrosis transmembrane conductance regulator lung epithelial cells: involvement of extracellular signal-regulated protein kinase 1/2 and c-Jun-NH2-terminal kinase signaling.
    Roque T; Boncoeur E; Saint-Criq V; Bonvin E; Clement A; Tabary O; Jacquot J
    J Pharmacol Exp Ther; 2008 Sep; 326(3):949-56. PubMed ID: 18574003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.